Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection

HPB

Volumn 14, Issue 4, 2012, Pages 247-253

  Matono, Rumi ^a   Yoshiya, Shohei ^a   Motomura, Takashi ^a   Toshima, Takeo ^a   Kayashima, Hiroto ^a   Masuda, Toshiro ^a   Yoshizumi, Tomoharu ^a   Taketomi, Akinobu ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Local therapy; Longterm survival; Main portal vein tumour thrombus; Recurrent pattern

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER NODULE; LIVER RESECTION; MAIN PORTAL VEIN TUMOR THROMBUS; MALE; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; RADIOFREQUENCY ABLATION; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR THROMBUS;

EID: 84858007657     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00436.x     Document Type: Article

References (42)

1. Okuda K. (1992) Hepatocellular carcinoma: recent progress. Hepatology 15:948-963.
2. Liver Cancer Study Group of Japan. (2003) The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 2nd English edn. Tokyo: Kanehara.
3. Llovet JM, Bustamante J, Castelle A, Vilana R, Ayuso Mdel C, Sala M et al. (1999) Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62-67. (Pubitemid 29023987)
4. Villa E, Moles A, Ferreti I, Buttafoco P, Grottola A, Del Buono M et al. (2000) Natural history of inoperable hepatocellular carcinoma: oestrogen receptors' status in the tumour is the strongest prognostic factors for survival. Hepatology 32:233-238. (Pubitemid 30614655)
5. Ikai I, Hatano E, Hasegawa S, Fujii H, Taura K, Uyama N et al. (2006) Prognostic index for patients with hepatocellular carcinoma combined with tumour thrombosis in the major portal vein. J Am Coll Surg 202:431-438. (Pubitemid 43356217)
6. Le Treut YP, Hardwigsen J, Ananian P, Saïsse J, Grégoire E, Richa H et al. (2006) Resection of hepatocellular carcinoma with tumour thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10:855-862. (Pubitemid 43850379)
7. Kondo K, Chijiwa K, Kai M, Otani K, Nagaike K, Ohuchida J et al. (2009) Surgical strategy for hepatocellular carcinoma patients with portal vein tumour thrombus based on prognostic factors. J Gastrointest Surg 13:1078-1083.
8. Ban D, Shimada K, Yamamoto Y, Nara S, Esaki M, Sakamoto Y et al. (2009) Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein. J Gastrointest Surg 13:1921-1928.
9. Shi J, Lai E, Li N, Guo W, Xue J, Lau W et al. (2010) Surgical treatment of hepatocellular carcinoma with portal vein tumour thrombus. Ann Surg Oncol 17:2073-2080.
10. Inoue Y, Hasegawaw K, Ishizawa T, Aoki T, Sano K, Beck Y et al. (2009) Is there any difference in survival according to the portal vein thrombectomy method in patients with hepatocellular carcinoma? Surgery 145:9-19.
11. Shirabe K, Takeishi K, Taketomi A, Uchiyama H, Kayashima H, Maehara Y. (2011) Improvement of longterm outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg 35:1072-1084.
12. Miyagawa M, Makuuchi M. (2006) Treatment of hepatocellular carcinoma accompanied by portal vein thrombus. World J Gastroenterol 12:7561-7567.
13. Okazaki M, Higashihara H, Koganemaru HE. (1991) Transcatheter arterial embolization for inoperative hepatocellular carcinoma. Jpn J Clin Radiol 36:535-539.
14. Chung JW, Park JH, Han JK, Choi BI, Han MC. (1995) Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR Am J Roentgenol 165:315-321.
15. Georgiades CS, Hong K, D'Angelo M, Geschwind JF. (2005) Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16:1653-1659. (Pubitemid 44431162)
16. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D et al. (1994) Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 35:1782-1787. (Pubitemid 24346799)
17. Ando E, Yamashita F, Tanaka M, Tanigawa K. (1997) A novel chemotherapy for advanced hepatocellular carcinoma with tumour thrombosis of the main trunk of the portal vein. Cancer 79:1890-1896. (Pubitemid 27200371)
18. Itamoto T, Nakahara H, Tashiro H, Haruta N, Asahara T, Naito A et al. (2002) Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable hepatocellular carcinoma with tumour thrombus of the portal vein. J Surg Oncol 80:143-148. (Pubitemid 34747619)
19. Yamasaki T, Kurokawa H, Shirahashi H, Kuwano N, Hironaka K, Masuhara M et al. (2002) Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Hepatol Res 23:7-17. (Pubitemid 36113463)
20. Urabe T, Kaneko S, Matsushita E, Unoura M, Kobayashi K. (1998) Clinical pilot study of intrahepatic arterial chemotherapy with methotrexale, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma. Oncology 55:39-47. (Pubitemid 128707622)
21. Kaneko S, Urabe T, Kobayashi K. (2002) Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis. Oncology 62 (Suppl. 1):69-73. (Pubitemid 34702023)
22. Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T et al. (2005) Treatment of hepatocellular carcinoma with main portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer 93:557-564. (Pubitemid 43079999)
23. Obi S, Yoshida H, Toune R, Unuma T, Kanda M, Sato S et al. (2006) Combination therapy of intra-arterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal vein invasion. Cancer 106:1990-1997. (Pubitemid 43673215)
24. Tazawa J, Maeda M, Sakai Y, Yamane M, Ohbayashi H, Kakinuma S et al. (2001) Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 16:660-665. (Pubitemid 34188841)
25. Ishikura S, Ogino T, Furuse J, Satake M, Baba S, Kawashima M et al. (2002) Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumour thrombus. Am J Clin Oncol 25:189-193. (Pubitemid 34293077)
26. Yamada K, Izaki K, Sugimoto K, Mayahara H, Morita Y, Yoden E et al. (2003) Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumour thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57:113-119. (Pubitemid 36959746)
27. Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH et al. (2005) A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or interior vena cava tumour thrombus. Int J Radiat Oncol Biol Phys 61:432-443. (Pubitemid 40164438)
28. Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW et al. (2005) Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 103:2419-2426. (Pubitemid 40686589)
29. Hata M, Tokuuye K, Sugahara S, Kagei K, Igaki H, Hashimoto T et al. (2005) Proton beam therapy for hepatocellular carcinoma with portal vein tumour thrombus. Cancer 104:794-801. (Pubitemid 41113680)
30. Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T et al. (1996) Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 78:2094-2100. (Pubitemid 26367601)
31. Itoh S, Morita K, Ueda S, Sugimachi K, Yamashita Y, Gion T et al. (2009) Longterm results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. Ann Surg Oncol 16:3299-3307.
32. Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T et al. (2009) Impact of des-gamma-carboxy prothrombin and tumour size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 87:531-537.
33. Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S et al. (2009) Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant 9:2362-2371.
34. Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S et al. (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95:235-240.
35. Yue P, Gao ZH, Xue X, Cui SX, Zhao CR, Yuan YI et al. (2011) Des-gcarboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK 1/2 MAPK signalling pathway. Eur J Cancer 47:1115-1124.
36. Wang SB, Cheng YN, Cui SX, Zhong JL, Ward SG, Sun LR et al. (2009) Des-g-carboxyl prothrombin stimulates human vascular endothelial cell growth and migration. Clin Exp Metastasis 26:469-477.
37. Fujikawa T, Shihara H, Yamamoto K. (2009) Significance of des-gammacarboxy proliferation production in hepatocellular carcinoma. Acta Med Okayama 63:299-304.
38. Murata K, Suzuki H, Okano H, Oyamada T, Yasuda Y, Sakamoto A. (2009) Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. Int J Oncol 35:1005-1014.
39. Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, Ohigashi H et al. (2006) The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg 192:46-51. (Pubitemid 43849603)
40. Nagano H. (2010) Treatment of advanced hepatocellular carcinoma: intraarterial infusion chemotherapy combined with interferon. Oncology 78 (Suppl. 1):142-147.
41. Yamamoto T, Nagano H, Imai Y, Fukuda K, Matsumoto H, Kondo M et al. (2007) Successful treatment of multiple hepatocellular carcinoma with tumour thrombi in the major portal vein branches by intra-arterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy. Int J Clin Oncol 12:150-154. (Pubitemid 46632456)
42. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390.